Indian drug makers such as CiplaBSE 0.87 % and GlenmarkBSE 0.16 % are among some 30 companies bidding for tens of products to be hived off in the US, the world’s biggest pharma market, as part of Teva’s acquisition of Allergan’s generics business. Last August, Israel-based Teva Pharmaceutical Industries sealed a landmark $40.5-billion deal to buy the generics business of Irish firm Allergan Inc, following its failed and acrimonious chase for arch rival Mylan. By regulation .. Read more at: http://economictimes.indiatimes.com/articleshow/49838708.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Source: Economic TimesCipla, Glenmark in race for hived-off Teva-Allergan generics in US
Industry: Pharmaceutical 2015-11-19
